{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,21]],"date-time":"2024-02-21T14:27:19Z","timestamp":1708525639390},"reference-count":20,"publisher":"Walter de Gruyter GmbH","issue":"7-8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,1,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We report the use of continuous subcutaneous hydrocortisone infusion in an adolescent patient with primary adrenal insufficiency. This novel hydrocortisone delivery method proved to be a feasible, well-tolerated and safe option for selected patients with poor response to conventional therapy.<\/jats:p>","DOI":"10.1515\/jpem-2014-0473","type":"journal-article","created":{"date-parts":[[2015,7,13]],"date-time":"2015-07-13T08:57:51Z","timestamp":1436777871000},"source":"Crossref","is-referenced-by-count":2,"title":["Successful use of continuous subcutaneous hydrocortisone infusion after bilateral adrenalectomy secondary to bilateral pheochromocytoma"],"prefix":"10.1515","volume":"28","author":[{"given":"Julia R.","family":"Broussard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naim","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","reference":[{"key":"ref231","first-page":"99","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of disease a randomized clinical trial","author":"Oksnes","year":"2014"},{"key":"ref31","first-page":"361","article-title":"Adrenal insufficiency","author":"Arlt","year":"2003","journal-title":"Lancet"},{"key":"ref101","first-page":"157","article-title":"ES Continuous subcutaneous hydrocortisone infusion in disease","volume":"12","author":"Lovas","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"ref111","first-page":"99","article-title":"Continuous subcutaneous hydrocortisone infusion versus oral hydrocortisone replacement for treatment of disease a randomized clinical trial","author":"Oksnes","year":"2014"},{"key":"ref141","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.2005.02320.x","article-title":"Why is the management of glucocorticoid deficiency still controversial : a review of the literature","author":"Crown","year":"2005","journal-title":"Clin Endocrinol"},{"key":"ref81","first-page":"148","article-title":"disturbances in patients with disease","author":"Lovas","year":"2003","journal-title":"Sleep Eur J Endocrinol"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.2006.02544.x","article-title":"Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia","volume":"65","author":"Merza","year":"2006","journal-title":"Clin Endocrinol"},{"key":"ref131","first-page":"106","article-title":"Dexamethasone treatment of virilizing congenital adrenal hyperplasia : the ability to achieve normal growth","author":"Rivkees","year":"2000","journal-title":"Pediatrics"},{"key":"ref161","first-page":"144","article-title":"Chronopharmacology of hydrocortisone alpha - fluorohydrocortisone in the treatment for congenital adrenal hyperplasia","author":"Moeller","year":"1985","journal-title":"Eur J Pediatr"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1365-2265.2005.02320.x","article-title":"Why is the management of glucocorticoid deficiency still controversial : a review of the literature","author":"Crown","year":"2005","journal-title":"Clin Endocrinol"},{"key":"ref151","first-page":"361","article-title":"Adrenal insufficiency","author":"Arlt","year":"2003","journal-title":"Lancet"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.2006.02544.x","article-title":"Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia","volume":"65","author":"Merza","year":"2006","journal-title":"Clin Endocrinol"},{"key":"ref11","first-page":"106","article-title":"Dexamethasone treatment of virilizing congenital adrenal hyperplasia : the ability to achieve normal growth","author":"Rivkees","year":"2000","journal-title":"Pediatrics"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","author":"Flipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref41","first-page":"144","article-title":"Chronopharmacology of hydrocortisone alpha - fluorohydrocortisone in the treatment for congenital adrenal hyperplasia","author":"Moeller","year":"1985","journal-title":"Eur J Pediatr"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","author":"Flipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"ref221","first-page":"157","article-title":"ES Continuous subcutaneous hydrocortisone infusion in disease","volume":"12","author":"Lovas","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"ref201","first-page":"148","article-title":"disturbances in patients with disease","author":"Lovas","year":"2003","journal-title":"Sleep Eur J Endocrinol"},{"key":"ref01","first-page":"143","article-title":"Prednisolone in the treatment of adrenal insufficiency : a re - evaluation of relative potency","author":"Punthakee","year":"2003","journal-title":"J Pediatr"},{"key":"ref121","first-page":"143","article-title":"Prednisolone in the treatment of adrenal insufficiency : a re - evaluation of relative potency","author":"Punthakee","year":"2003","journal-title":"J Pediatr"}],"container-title":["Journal of Pediatric Endocrinology and Metabolism"],"original-title":[],"link":[{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2014-0473\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,22]],"date-time":"2021-04-22T01:38:37Z","timestamp":1619055517000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.degruyter.com\/document\/doi\/10.1515\/jpem-2014-0473\/html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,1]]},"references-count":20,"journal-issue":{"issue":"7-8"},"URL":"https:\/\/doi.org\/10.1515\/jpem-2014-0473","relation":{},"ISSN":["2191-0251","0334-018X"],"issn-type":[{"value":"2191-0251","type":"electronic"},{"value":"0334-018X","type":"print"}],"subject":[],"published":{"date-parts":[[2015,1,1]]}}}